Cargando…
Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
INTRODUCTION: Valproic acid (VPA) is widely used for the treatment of epilepsy, migraine, and a variety of psychiatric conditions. The reported incidences of hyperammonemia induced by VPA use is variable. The purpose of this study is to evaluate the incidence of VPA-induced hyperammonemia in the gen...
Autores principales: | McMorris, Tressa, Chu, Angela, Vu, Lynn, Bernardini, Amanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287865/ https://www.ncbi.nlm.nih.gov/pubmed/34316420 http://dx.doi.org/10.9740/mhc.2021.07.243 |
Ejemplares similares
-
Hyperammonemia Associated with Valproic Acid Concentrations
por: Vázquez, Marta, et al.
Publicado: (2014) -
Valproic Acid-Induced Hyperammonemia in the Elderly: A Review of the Literature
por: Mittal, Vikrant, et al.
Publicado: (2009) -
Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy
por: Tseng, Yu-Lung, et al.
Publicado: (2014) -
Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient
por: Aiyer, Rohit, et al.
Publicado: (2016) -
Valproic acid–induced hyperammonemia: Incidence, clinical significance, and treatment management
por: Baddour, Elisa, et al.
Publicado: (2018)